Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Up 49.7% in May

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTFGet Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 704,500 shares, a growth of 49.7% from the May 15th total of 470,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Recordati Industria Chimica e Farmaceutica Stock Performance

Shares of OTCMKTS:RCDTF remained flat at $51.60 during trading on Friday. The company’s 50-day moving average price is $51.60 and its 200-day moving average price is $49.97. Recordati Industria Chimica e Farmaceutica has a 12-month low of $51.60 and a 12-month high of $51.98. The company has a current ratio of 1.28, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80.

About Recordati Industria Chimica e Farmaceutica

(Get Free Report)

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.

See Also

Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.